Fox Chase Cancer Center News

Dear Colleagues, As I am sure you have heard, Temple University and Temple Health lost a great friend this weekend with the tragic death of Lewis Katz, who served as a long-time member of the University's Board of Trustees and a member of the Boards of Temple University Health System (TUHS) and Fox Chase Cancer Center (FCCC).

CHICAGO, IL (May 30, 2014)—Fox Chase Cancer Center researchers have carried out the first retrospective analysis of adjuvant chemotherapy’s impact on overall survival in patients with stage III soft tissue sarcomas (STS), adjusted for socioeconomic status and other variables. The findings show that regardless of socioeconomic status and comorbidities, adjuvant chemotherapy improved survival by approximately 23 percent in stage III STS.

CHICAGO, IL (May 30, 2014)—The use of chemotherapy before surgery to remove ovarian cancer has increased dramatically in recent decades, particularly among certain patients, according to a new analysis from Fox Chase Cancer Center that will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology.

CHICAGO, IL (May 30, 2014)—Patients with muscle-invasive bladder cancer often benefit from chemotherapy before surgery to remove the tumor, but a test of one regimen by researchers at Fox Chase Cancer Center was halted when too many people experienced serious side effects such as heart attacks and blood clots in the legs and lungs.

CHICAGO, IL (May 30, 2014)—More than a quarter of HIV+ patients are also infected with the Hepatitis C virus (HCV), which may complicate treatment and care decisions after a cancer diagnosis. The specifics of those complications haven’t been well-researched in the past. Results from a new Fox Chase Cancer Center study on this patient population may start filling in that gap.

CHICAGO, IL (May 30, 2014)—Patients with AIDS-related lymphomas (ARL) may face an increased risk of central nervous system involvement (CNSi) compared to other lymphomas. The effect of CNSi on survival outcomes, however, hasn’t been thoroughly examined until now.

PHILADELPHIA, PA (May 20, 2014) This week, Dr. Uzzo received the prestigious 2014 American Urologic Association’s (AUA) Residents Committee Teaching Award at the organization’s 2014 Annual Meeting in Orlando, FL. Dr. Uzzo is the Chair of the Department of Surgery at Fox Chase Cancer Center, and holds the G. Willing “Wing” Pepper Chair in Cancer Research.

PHILADELPHIA, PA (May 14, 2014)—Last fall, Trustee Lewis Katz, CST '63, surprised the Temple community by announcing a $25 million commitment to the university—the largest single pledge in Temple's history.

Now Katz has announced where the funds are going: to support the educational and research mission of Temple's School of Medicine. In recognition of Katz's commitment and his lifetime of efforts on behalf of the university, Temple's Board of Trustees will name the university's School of Medicine for Katz.